mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.6 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.029 |
0.6 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |